Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Disease-specific therapy of idiopathic inflammatory demyelinating disorders.
Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study.
Multiple sclerosis: Linking disability and spinal cord imaging outcomes in MS.
Potential Beneficial Effects of Marine Peptide on Human Neuron Health.
Simvastatin Treatment of Patients With Acute Optic Neuritis
Corneal Sensitivity and Tear Function in Neurodegenerative Diseases.
Relationship between contrast sensitivity test and disease severity in multiple sclerosis patients.
Myeloid Kruppel-like factor 2 deficiency exacerbates neurological dysfunction and neuroinflammation in a murine model of multiple sclerosis.
Cortical excitability changes over time in progressive multiple sclerosis.
Pain and spinal cord imaging measures in children with demyelinating disease.
Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis.
Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death.
MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Criteria improving multiple sclerosis diagnosis at the first MRI.
Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse.
Oligodendrocytes: Myelination and Axonal Support.
New analysis indicates that Novartis drug Gilenya shows significant early effect on reducing brain volume loss at 6 months
Developments in autoimmune channelopathies.
[Pharmaceutical prescription for multiple sclerosis : Evaluation of pharmaceutical consumption at private health insurance.]
Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems.
New hope for multiple sclerosis patients.
Multicenter measurements of myelin water fraction and geometric mean T2 : Intra- and intersite reproducibility.
Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease.
Endovascular diagnosis and management of chronic cerebrospinal venous insufficiency: retrospective analysis of 30-day morbidity and mortality in 95 consecutive patients.
Interpreting therapeutic effect in multiple sclerosis via MRI contrast enhancing lesions: now you see them, now you don't.

Pages